This strengthened the suspicion of congenital myotonic dystrophy type 1 (DM1) in the newborn. Autosomal dominant congenital DM1 is due to a CTG repeat expansion of the DMPK (dystrophia myotonica ...
In recent years, a growing understanding of myotonic dystrophy type 1 (DM1)—an often fatal, devastating, rare neuromuscular disorder that causes muscle weakness and other life-limiting ...
Click here to learn more from DelveInsight’s latest report @ Myotonic Dystrophy Market Size AMO-02 (tideglusib) is under development for congenital myotonic dystrophy (CDM) and potential use in ...
Patients with myotonic dystrophy have smaller hearts, and lower systolic and diastolic blood pressures and pulse rates. They have impaired autonomic reflexes, measured by orthostatic, Valsalva ...
In 2023, the analyst reported a breakdown of Myotonic Dystrophy Type 1 cases in the US, with nearly 540 congenital, 3,893 infantile, 1,515 juvenile, 39,686 adult-onset, and 8,435late-onset cases.
Dyne Therapeutics Inc. is eyeing accelerated approval for its myotonic dystrophy type 1 treatment after reviewing new results from a phase I/II study. DYNE-101, an oligonucleotide antisense and DMPK ...